HONG KONG: The Intellectual Property Department (IPD) of Hong Kong has granted another patent for Episurf Medical (NASDAQ: EPIS B).
The patent, entitled “Method and node for manufacturing a surgical kit for cartilage repair”, covers a medical image segmentation process for 3D visualisation of anatomical joints.
“Image segmentation is a part of the technology around Episurf Medical’s individualised joint implants and surgical instruments. This patent adds on to previous patents within this area and broadens the protection for the company’s imaging technology in Hong Kong, says Katarina Flodström, COO, Episurf Medical.
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm.